| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG. |
|
Medicine details |
|
| Medicine name | human normal immunoglobulin (HyQvia®) |
| Formulation | 100 mg/ml solution for infusion for subcutaneous use |
| Reference number | 4679 |
| Indication | Replacement therapy in adults, children and adolescents (0‑18 years) in secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l |
| Company | Takeda UK Ltd |
| BNF chapter | Immunological products & vaccines |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 25/10/2021 |